Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$279,320
+$37,907 QoQ
Shares Held
1,110
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#3,687
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Solstein Capital, LLC holds $2,332,481 across 10 Drug Manufacturers - General names. ABBV ranks #2 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,355 | $1,625,227 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,110 | $279,320 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,036 | $130,888 | |
| 4 | PFE |
Pfizer Inc
|
2,903 | $69,904 | |
| 5 | JNJ |
Johnson & Johnson
|
234 | $59,428 | |
| 6 | AMGN |
Amgen Inc
|
133 | $48,161 | |
| 7 | NVS |
Novartis AG
|
300 | $47,016 | |
| 8 | NVO |
Novo Nordisk A S
|
794 | $38,064 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $279,320 | 1,110 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $241,413 | 1,110 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $333,595 | 1,460 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $338,048 | 1,460 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $271,005 | 1,460 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $232,567 | 1,110 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $197,247 | 1,110 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $219,202 | 1,110 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $190,387 | 1,110 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $202,131 | 1,110 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $208,434 | 1,345 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $200,485 | 1,345 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $181,211 | 1,345 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $214,352 | 1,345 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $217,365 | 1,345 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $180,512 | 1,345 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $219,784 | 1,435 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $232,627 | 1,435 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $194,299 | 1,435 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $154,793 | 1,435 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $161,638 | 1,435 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $114,821 | 1,061 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $81,896 | 935 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $91,798 | 935 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $62,704 | 823 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||